BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2014 9:24:00 PM | Browse: 1332 | Download: 1399
Publication Name World Journal of Gastroenterology
Manuscript ID 11599
Country United States
Received
2014-05-28 12:07
Peer-Review Started
2014-05-28 21:09
To Make the First Decision
2014-07-09 12:10
Return for Revision
2014-07-17 15:03
Revised
2014-08-27 10:51
Second Decision
2014-11-10 11:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-11-19 09:16
Articles in Press
2014-11-19 09:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-11-20 18:16
Typeset the Manuscript
2014-12-11 15:32
Publish the Manuscript Online
2014-12-20 19:42
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy
Manuscript Source Invited Manuscript
All Author List Ting-Ting Li, Shuji Ogino and Zhi Rong Qian
Funding Agency and Grant Number
Funding Agency Grant Number
United States National Institute of Health (NIH) P01 CA87969 (to SE Hankinson)
United States National Institute of Health (NIH) UM1 CA167552
United States National Institute of Health (NIH) P01 CA55075 (to WC Willett)
United States National Institute of Health (NIH) R01 CA137178 (to AT Chan)
United States National Institute of Health (NIH) P50 CA127003 (to CS Fuchs)
United States National Institute of Health (NIH) R01 CA151993 (to S Ogino)
Bennett Family Fund for Targeted Therapies Research
Entertainment Industry Foundation through National Colorectal Cancer Research Alliance
Corresponding Author Zhi-Rong Qian, MD, PhD, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Room M420, Boston, MA 02215, United States. zhirong_qian@dfci.harvard.edu
Key Words Toll-like receptor; Colorectal cancer; Carcinogenesis; Prognosis; Cancer therapy
Core Tip Toll-like receptors (TLRs) are innate immune sensors which can recognize inflammatory mediators. TLRs have been shown to mediate inflammatory response and maintain epithelial barrier homeostasis. Inflammation is a risk factor for many cancers including colorectal cancer (CRC). The key molecules involved in inflammation-driven carcinogenesis include TLRs. In this paper, we reviewed TLR signaling in CRC from carcinogenesis to cancer therapy.
Publish Date 2014-12-20 19:42
Citation Li TT, Ogino S, Qian ZR. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. World J Gastroenterol 2014; 20(47): 17699-17708
URL http://www.wjgnet.com/1007-9327/full/v20/i47/17699.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i47.17699
Full Article (PDF) WJG-20-17699.pdf
Full Article (Word) WJG-20-17699.doc
Manuscript File 11599-Review.doc
Answering Reviewers 11599-Answering reviewers.pdf
Copyright License Agreement 11599-Copyright assignment.pdf
Peer-review Report 11599-Peer review(s).pdf
Scientific Misconduct Check 11599-CrossCheck.jpg
Scientific Editor Work List 11599-Scientific editor work list.pdf